Angelika Iftner

2.3k citations

26 papers · 637 indexed · h-index 14

Impact in

Epidemiology top 5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Nonmelanoma Skin Cancer Studies
Microbiology top 5%
- Reproductive tract infections research

Papers in

Microbiology 6
- Reproductive tract infections research 6
Epidemiology 20
- Cervical Cancer and HPV Research 19
- Hepatitis B Virus Studies 6
- Nonmelanoma Skin Cancer Studies 3

Co-authors: Thomas Iftner Stefanie J. Klug Claus Garbe Sharon P. Wilczynski Andreas Blum Barbara Holz Wim Quint Karl Ulrich Petry
Journals: BMC Infectious Diseases (5 papers)Journal of Clinical Microbiology (2 papers)Journal of Medical Virology (2 papers)Virology (2 papers)Cornea (1 paper)
Partner nations: Germany Denmark United Kingdom

In The Last Decade

Angelika Iftner

25 papers receiving 608 citations

Peers

Countries citing papers authored by Angelika Iftner

Since Specialization

Citations

This map shows the geographic impact of Angelika Iftner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Iftner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Iftner more than expected).

Fields of papers citing papers by Angelika Iftner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika Iftner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Iftner. The network helps show where Angelika Iftner may publish in the future.

Co-authors

The 25 scholars most cited alongside Angelika Iftner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelika Iftner Line = papers co-authored together Angelika Iftner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Absence of detectable SARS-CoV-2 replication in ex vivo cultured cornea and cornea-derived epithelial cells Graefe s Archive for Clinical and Experimental Ophthalmology ·Tarek Bayyoud, Mark Dredze, E. G. N. S. H. Kumara, P Murshida Nusrath, Ramona Businger, Dan Hu, Angelika Iftner, Sebastian Thaler, Michael Schindler	2022	1
2	Antibody Response against SARS-CoV-2 and Seasonal Coronaviruses in Nonhospitalized COVID-19 Patients mSphere ·Natalia Ruétalo, Ramona Businger, Karina Althaus, Charles Edward Johnson, Yuta Fujikawa, 上田嘉助, Angelika Iftner, Pla Wei, Klaus Hamprecht, Bertram Flehmig, Tamam Bakchoul, Markus F. Templin, Michael Schindler	2021	12
3	Severe acute respiratory Syndrome-Coronavirus-2: Can it be detected in the retina? PLoS ONE ·Tarek Bayyoud, Angelika Iftner, Thomas Iftner, Karl Ulrich Bartz‐Schmidt, Focke Ziemssen, Hans Bösmüller, Falko Fend, Jens Martin Rohrbach, Marius Ueffing, Michael Schindler, Sebastian Thaler	2021	6
4	Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis BMC Infectious Diseases ·洪文霞, Thomas Iftner, Angelika Iftner, M. Irfana Amrin, Chao-Ting Huang, Alexander Luyten, Masaaki Yasukawa, Nicole Jolicoeur, Karl Ulrich Petry	2021	4
5	Absence of Severe Acute Respiratory Syndrome-Coronavirus-2 RNA in ocular tissues American Journal of Ophthalmology Case Reports ·Tarek Bayyoud, Angelika Iftner, Thomas Iftner, Karl Ulrich Bartz‐Schmidt, Marius Ueffing, Michael Schindler, Sebastian Thaler	2020	13
6	Modifiable Risk-factors for Keratinocyte Cancers in Australia: A Case-control Study Acta Dermato Venereologica ·Lina María Serna-Higuita, Simone L. Harrison, Petra Büttner, M. A. Glasby, Beverly Raasch, Angelika Iftner, Claus Garbe, Peter Martus, Thomas Iftner	2018	3
7	Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany Journal of Clinical Microbiology ·Thomas Iftner, Farzad Pourghazi, Alejandra Castañón, Rebecca Landy, Barbara Holz, Lin Zhou, Angelika Iftner, Annette Staebler, D. Wallwiener, Claus Hann von Weyhern, Felix Neis, Juliane Haedicke, Peter Martus, Sara Y. Brucker, Melanie Henes, Peter Sasieni	2018	28
8	Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens BMC Infectious Diseases ·Thomas Iftner, Lisa Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke, Михаил Александрович Гоник, Reinhard von Wasielewski, Peter Martus, Gerd Boehmer	2016	2
9	Detection of mutation-specific epidermal growth factor receptor (E746–A750del) and lack of detection of human papillomavirus in oral squamous cell carcinoma International Journal of Oral and Maxillofacial Surgery ·Martin Grimm, Thomas Iftner, Ray Sayani, Angelika Iftner, Johannes Peters, Adelheid Munz, Siegmar Reinert	2014	4
10	A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off BMC Infectious Diseases ·Gerd Boehmer, Lisa Wang, Angelika Iftner, Barbara Holz, Juliane Haedicke, Reinhard von Wasielewski, Peter Martus, Thomas Iftner	2014	10
11	A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion Virology Journal ·Paul‐Stefan Mauz, Peter Donhauser, Ralf Kurth, Michael Pawlita, Martin Holderried, Mengran Xu, Angelika Iftner, Frank Stubenrauch, Karl Sotlar, Thomas Iftner	2014	11
12	Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany BMC Infectious Diseases ·Karl Ulrich Petry, Alexander Luyten, Fransiskus Vilisianus Sales, Angelika Iftner, Dahlia Misrika, Axel Reinecke‐Lüthge, C Ricardo Argüello, Renate Schulze‐Rath, Thomas Iftner	2013	28
13	Persistence and reappearance of high-risk human papillomavirus after conization Gynecologic Oncology ·Tadashi Ohira, Lene Drasbek Huusom, Klaus Kaae Andersen, Angelika Iftner, Luise Cederkvist, Edith I. Svare, Thomas Iftner, Susanne K. Kjær	2013	14
14	Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany BMC Infectious Diseases ·Karl Ulrich Petry, Alexander Luyten, Fransiskus Vilisianus Sales, Angelika Iftner, Dahlia Misrika, Renate Schulze‐Rath, Thomas Iftner	2012	22
15	Prevalence of low‐risk and high‐risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: An epidemiological observational study Journal of Medical Virology ·Thomas Iftner, Sonja Eberle, Angelika Iftner, Barbara Holz, Norbert Banik, Wim Quint, Andreas Straube	2010	45
16	Human papillomavirus in basal cell carcinoma - a pilot study. Thomas Iftner, Angelika Iftner, Petra Büttner, Simone L. Harrison, Е. А. Донская, Beverly Raasch, Claus Garbe	2009	1
17	Comparison of the performance of different HPV genotyping methods for detecting genital HPV types Journal of Medical Virology ·Stefanie J. Klug, Anco Molijn, Betti Schopp, Barbara Holz, Angelika Iftner, Wim Quint, Peter J.F. Snijders, Karl Ulrich Petry, Susanne K. Kjær, Christian Munk, Thomas Iftner	2008	84
18	The E7 protein of the cottontail rabbit papillomavirus immortalizes normal rabbit keratinocytes and reduces pRb levels, while E6 cooperates in immortalization but neither degrades p53 nor binds E6AP Virology ·Tina Ganzenmueller, Meisam Ahmadzade, 赵淑珍, C.A. Flett, Angelika Iftner, Thomas Hiller, Fatih Maybarskan, Jane M. Lister, Frank Stubenrauch, Thomas Iftner	2007	18
19	The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. PubMed ·Angelika Iftner, Stefanie J. Klug, Claus Garbe, Andreas Blum, M. Hagimoto, Sharon P. Wilczynski, Thomas Iftner	2003	164
20	Synthesis of Viral DNA and Late Capsid Protein L1 in Parabasal Spinous Cell Layers of Naturally Occurring Benign Warts Infected with Human Papillomavirus Type 1 Virology ·Kiyofumi Egawa, Angelika Iftner, John Doorbar, Yumi Honda, Thomas Iftner	2000	18

About Angelika Iftner

Angelika Iftner is a scholar working on Microbiology, Epidemiology, Ophthalmology, Obstetrics and Gynecology and Surgery, having authored 26 papers that have together received 637 indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (19 papers), Genital Health and Disease (10 papers), Reproductive tract infections research (6 papers), Hepatitis B Virus Studies (6 papers), Molecular Biology Techniques and Applications (4 papers), Retinal and Optic Conditions (4 papers), Nonmelanoma Skin Cancer Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Epidemiology (527 citations), Microbiology (88 citations), Dermatology (58 citations), Ophthalmology (54 citations) and Obstetrics and Gynecology (46 citations). Angelika Iftner has collaborated with scholars based in Germany, Denmark and United Kingdom. Frequent co-authors include Thomas Iftner, Stefanie J. Klug, Claus Garbe, Sharon P. Wilczynski, Andreas Blum, Barbara Holz, Wim Quint, Karl Ulrich Petry, Susanne K. Kjær and Peter J.F. Snijders. Their work appears in journals such as BMC Infectious Diseases, Journal of Clinical Microbiology, Journal of Medical Virology, Virology and Cornea.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact